NKILT moves from stealth mode to active fundraising

April 19, 2022 -- ScienceBoard.net recently caught up with NKILT Therapeutics leaders Raphael Ognar and Henri Bayle at the 2022 American Association for Cancer Research (AACR) Annual Meeting in New Orleans.

Since ScienceBoard first met with CEO and co-founder Raphael Ognar at the Society for Immunotherapy of Cancer's 2021 annual meeting last November, NKILT has moved from stealth mode into active fund seeking that will allow them to add to their leadership and lab teams and launch preclinical studies soon.

Ognar said the company has started to target and hire their science lab personnel and hopes to begin lab work in the coming weeks. NKILT has also filed several patents on its intellectual property to secure the uniqueness and specificity of their technology, which is based on the killer cell immunoglobulin-like receptors concept and the activation of the natural killer cell concept.

"We are growing, building, and ready to accelerate as soon as we increase our early funding," Ognar said.

Click on the video below to learn more.

AACR 2022 video: DCIS lesions may affect treatment management
NEW ORLEANS -- In an interview with ScienceBoard.net, Tanjina Kader, PhD, of the Women's Cancer Research Program at the Sir Peter MacCallum Cancer...
Agilent demonstrates cell analysis solutions for cancer at AACR 2022
Agilent Technologies will display its cancer research tools for the enhanced study of cell functionality, characteristics, and other properties at the...
AACR 2022 video: Project GENIE spurs sharing of real-world data
At this week's American Association for Cancer Research (AACR) 2022 annual meeting, ScienceBoard.net spoke with Shawn Sweeney, PhD, the director...
Why one industry veteran launched a new cancer immunotherapy company
WASHINGTON, DC - Raphaël Ognar spoke with ScienceBoard onsite at the Society for Immunotherapy of Cancer's 2021 annual meeting about the launch...

Copyright © 2022 scienceboard.net

Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter